Physician profile
Catherine Rapp
NPI 1285892950
$8,957.91
in general payments reported to CMS, 2019-2025
15 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $230 · 2021: $459 · 2022: $3,032 · 2023: $2,713 · 2024: $627 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,154 · Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,153.94 |
| Food and Beverage | $1,406.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $1,781.62 | 2022-2023 | Djo Surgical |
| Anika Therapeutics, INC. | $1,296.45 | 2023 | Ovomotion |
| Elite Orthopedics, LLC | $1,210.11 | 2022 | |
| Arthrex, INC. | $1,029.90 | 2025 | |
| Zimmer Biomet Holdings, INC. | $980.15 | 2022-2024 | Comprehensive Shoulder System |
| Smith+Nephew, INC. | $882.73 | 2019-2022 | |
| Catalyst Orthoscience | $682.06 | 2020-2024 | Catalyst Csr Shoulder System |
| Kairos Surgical INC | $422.55 | 2024-2025 | |
| Stryker Corporation | $261.92 | 2021-2024 | T2 Alpha, Conextions Tr Tendon Repair System-Implant Mechanism |
| Amgen INC. | $216.09 | 2022-2023 | Evenity |
| Depuy Synthes Sales INC. | $112.89 | 2021 | |
| Endo USA, INC. | $27.92 | 2024 | Xiaflex |
| Medical Device Business Services, INC. | $27.88 | 2025 | Inhance |
| Axogen | $15.54 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Medela LLC | $10.10 | 2024 | Invia Motion Endure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$125,053.31 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Rapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.